JP2024180560A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024180560A5 JP2024180560A5 JP2024179966A JP2024179966A JP2024180560A5 JP 2024180560 A5 JP2024180560 A5 JP 2024180560A5 JP 2024179966 A JP2024179966 A JP 2024179966A JP 2024179966 A JP2024179966 A JP 2024179966A JP 2024180560 A5 JP2024180560 A5 JP 2024180560A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- vector
- polypeptide
- seq
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025129697A JP2025163163A (ja) | 2018-09-28 | 2025-08-01 | ワクチンおよび方法 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1815956.6 | 2018-09-28 | ||
| GB201815956 | 2018-09-28 | ||
| JP2021542280A JP2022513326A (ja) | 2018-09-28 | 2019-09-27 | ワクチンおよび方法 |
| PCT/GB2019/052747 WO2020065349A2 (en) | 2018-09-28 | 2019-09-27 | Vaccines and methods |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021542280A Division JP2022513326A (ja) | 2018-09-28 | 2019-09-27 | ワクチンおよび方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025129697A Division JP2025163163A (ja) | 2018-09-28 | 2025-08-01 | ワクチンおよび方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024180560A JP2024180560A (ja) | 2024-12-26 |
| JP2024180560A5 true JP2024180560A5 (https=) | 2025-05-30 |
Family
ID=68501852
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021542280A Withdrawn JP2022513326A (ja) | 2018-09-28 | 2019-09-27 | ワクチンおよび方法 |
| JP2024179966A Pending JP2024180560A (ja) | 2018-09-28 | 2024-10-15 | ワクチンおよび方法 |
| JP2025129697A Pending JP2025163163A (ja) | 2018-09-28 | 2025-08-01 | ワクチンおよび方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021542280A Withdrawn JP2022513326A (ja) | 2018-09-28 | 2019-09-27 | ワクチンおよび方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025129697A Pending JP2025163163A (ja) | 2018-09-28 | 2025-08-01 | ワクチンおよび方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20220040284A1 (https=) |
| EP (1) | EP3856239A2 (https=) |
| JP (3) | JP2022513326A (https=) |
| CN (2) | CN113453710A (https=) |
| WO (1) | WO2020065349A2 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021403658A1 (en) * | 2020-12-16 | 2023-06-29 | Molecular Partners Ag | Recombinant cd3 binding proteins and their use |
| CA3211368A1 (en) * | 2021-03-09 | 2022-09-15 | Molecular Partners Ag | Novel darpin based cd123 engagers |
| WO2023275538A1 (en) * | 2021-06-28 | 2023-01-05 | Diosynvax Ltd | Beta-coronavirus vaccines |
| CN114807225B (zh) * | 2022-04-26 | 2024-01-16 | 吉林大学 | 一种抗羊口疮和绵羊痘的重组dna疫苗及其重组质粒 |
| CN117591664B (zh) * | 2023-04-25 | 2024-12-13 | 上海任意门科技有限公司 | 一种数据挖掘方法、装置及存储介质 |
| WO2025083402A1 (en) | 2023-10-16 | 2025-04-24 | Diosynvax Ltd | Coronavirus vaccines |
| GB202315888D0 (en) | 2023-10-17 | 2023-11-29 | Diosynvax Ltd | Influenza vaccines |
| DE102023130217A1 (de) * | 2023-11-01 | 2025-05-08 | Universität Leipzig, Körperschaft des öffentlichen Rechts | Verfahren zur Bestimmung der Immunogenität eines Antigens |
| GB202404264D0 (en) * | 2024-03-25 | 2024-05-08 | Univ Regensburg | Hemorrhagic fever vaccines |
| WO2026074282A1 (en) | 2024-10-01 | 2026-04-09 | Diosynvax Ltd. | Influenza vaccines |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1846439A2 (en) * | 2005-01-31 | 2007-10-24 | The Johns Hopkins University | Use of consensus sequence as vaccine antigen to enhance recognition of virulent viral variants |
| WO2013119683A1 (en) * | 2012-02-07 | 2013-08-15 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Computationally optimized broadly reactive antigens for h3n2, h2n2, and b influenza viruses |
| EP3188752A2 (en) * | 2014-09-03 | 2017-07-12 | Bavarian Nordic A/S | Recombinant modified vaccinia virus ankara (mva) filovirus vaccine |
| US10245313B2 (en) * | 2014-10-24 | 2019-04-02 | Versitech Limited | DNA motif compounds and methods for inducing specific antibodies and cellular immunity |
| US11701418B2 (en) * | 2015-01-12 | 2023-07-18 | Geovax, Inc. | Replication-deficient modified vaccinia Ankara (MVA) expressing Ebola virus glycoprotein (GP) and matrix protein (VP40) |
| EP3484507A1 (en) * | 2016-07-15 | 2019-05-22 | Janssen Vaccines & Prevention B.V. | Methods and compositions for inducing protective immunity against a marburg virus infection |
-
2019
- 2019-09-27 US US17/280,526 patent/US20220040284A1/en active Pending
- 2019-09-27 CN CN201980078442.9A patent/CN113453710A/zh active Pending
- 2019-09-27 CN CN202510697301.2A patent/CN121499810A/zh active Pending
- 2019-09-27 WO PCT/GB2019/052747 patent/WO2020065349A2/en not_active Ceased
- 2019-09-27 EP EP19801068.8A patent/EP3856239A2/en active Pending
- 2019-09-27 JP JP2021542280A patent/JP2022513326A/ja not_active Withdrawn
-
2024
- 2024-10-15 JP JP2024179966A patent/JP2024180560A/ja active Pending
-
2025
- 2025-08-01 JP JP2025129697A patent/JP2025163163A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024180560A5 (https=) | ||
| RU2733834C1 (ru) | Искусственный ген EctoS_SC2, кодирующий эктодомен гликопротеина S коронавируса SARS-CoV-2 с C-концевым тримеризующим доменом, рекомбинантная плазмида pStem-rVSV-EctoS_SC2, обеспечивающая экспрессию искусственного гена, и рекомбинантный штамм вируса везикулярного стоматита rVSV-EctoS_SC2, используемый для создания вакцины против коронавируса SARS-CoV-2 | |
| JP2025184979A5 (https=) | ||
| CN115850396B (zh) | 一种rsv纳米颗粒疫苗及其制备方法与应用 | |
| JP2003530093A5 (https=) | ||
| CA2220133A1 (en) | Recombinant vesiculoviruses and their uses | |
| WO2012172277A4 (en) | Simian adenovirus and hybrid adenoviral vectors | |
| JP2023522154A5 (https=) | ||
| US20170320918A1 (en) | Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefrom | |
| CN104311671A (zh) | 猫长效融合干扰素及其制备方法与应用 | |
| JP2025169249A5 (https=) | ||
| CN112552413A (zh) | 新型冠状病毒重组蛋白亚单位疫苗 | |
| CN111218477A (zh) | 靶向感染哺乳动物细胞的禽4型腺病毒载体及其应用 | |
| CN104829732A (zh) | 一种重组蛋白及其在昆虫杆状病毒表达系统中的表达方法 | |
| JP2002539781A5 (https=) | ||
| JP2023548838A5 (https=) | ||
| CN113430178B (zh) | 一种表达ii型单纯疱疹病毒蛋白的重组流感病毒株及其制备方法与应用 | |
| WO2022037095A1 (zh) | 优化的表达新型冠状病毒抗原的核苷酸序列及其应用 | |
| CN103554270A (zh) | 一种新型重组蛋白及其制备和应用 | |
| CN116904489B (zh) | 一种鸭坦布苏病毒核酸疫苗及应用 | |
| CN116785422B (zh) | 含有新型冠状病毒联合抗原的麻疹减毒疫苗及其拯救方法 | |
| CN102740872A (zh) | 用于在老年人中提供保护性免疫的方法和组合物 | |
| CN120350067A (zh) | 一种基于昆虫-杆状病毒系统制备人偏肺病毒核衣壳蛋白的方法 | |
| CN113402615B (zh) | 双位点嵌合巴氏杆菌PlpE抗原表位的兔出血症病毒VP60重组抗原及其制备和应用 | |
| CN115975053A (zh) | 靶向新型冠状病毒的疫苗 |